Results for tag: "Galactosemia Drug"

Galactosemia is a rare genetic disorder that affects the metabolism of galactose, a sugar found in dairy products and other foods. Endocrine and Metabolic Disorders Drugs are used to treat this disorder. These drugs are used to reduce the amount of galactose in the body, as well as to reduce the symptoms associated with the disorder. Common drugs used to treat galactosemia include galactose-1-phosphate uridyltransferase (GALT) enzyme replacement therapy, galactose-restricted diet, and lactose-free diet. The Galactosemia Drug market is a niche market, with a limited number of drugs available to treat the disorder. The market is expected to grow in the coming years, as more research is conducted into the disorder and new treatments are developed. Some companies in the Galactosemia Drug market include Sanofi, Pfizer, Novartis, and Merck. Show Less Read more